Outcomes of Angiotensin Converting Enzyme Inhibitor Management Strategies Prior to Coronary Artery Bypass
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 126 participants.
Also called NCT02096406
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 126 participants
- Sponsor
- Registry
-
NCT02096406
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT02096406. Randomized; no masking; primary purpose treatment. Start 2014-04 (registry gives no type); primary completion 2018-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Outcomes of Angiotensin Converting Enzyme Inhibitor Management Strategies Prior to Coronary Artery Bypass
- Acronym
- COMPACT
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- ACE/ARB continuation
- Intervention (Drug)
- ACE/ARB withdrawal
- Lead sponsor
- University of Alberta
Record details
- Record id
cardio:ct-nct02096406- Content hash
97e15ab824bc031eaaf5d01fcb6bb23702903870e6f4a7382f58c0a02fe4aec1